Top Highlights for February 2014: (Please click on read more to see details)
- Pharma sales in India expected to rise by 14.4 per cent to USD 27 billion in 2016:Deloitte. Read more
- Merck in partnership with Brazil's Bionovis & India's Dr. Reddy's Lab to step up its push into biosimilars which is forecasted to be worth $25 bn by 2020. Read more
- GlaxoSmithKline to raise its stake in Indian Pharma Unit by spending close to $2 billion. Read more
- India PE investments in healthcare & LifeScience sector increased from $191 million in Q3 2013 to $729 million in Q4 2013
- Lupin, India acquired Dutch company Nanomi company to expand its business in patented products.
- India's Jubilant expanded its drug discovery alliance with Belgium's Janssen Read more
- French Pierre Fabre and India's Aurigene in collaboration agreement for a new cancer therapeutic.Read more
- Cipla formed an India-specific strategic partnership with MSD to co-market anti HIV drug. Read more
- Baxter erects global R&D center at Bangalore, India.
Featured Opportunities and Aagami Updates: (Please click on link to view details)
1. Product Licensing opportunities:
- NEW ! Elores– to combat antimicrobial resistance – Looking for partner to Launch in US. Already launched in India and partnership completed for South Africa and South Korea.
- NEW ! Partnership sought for low cost, stable, safe, malaria cure which overcomes drug resistance and is ready for human clinical trials.